ACLARIS THERAPEUTICS INC. - COMMON STOCK

Aclaris Therapeutics to Participate in the William Blair Biotech Focus Conference 2021

08 июл 2021 06:00:00 Источник Nasdaq GlobeNewswire

Aclaris Announces Pricing of Public Offering of Common Stock

09 июн 2021 18:55:14 Источник Nasdaq GlobeNewswire

Aclaris Announces Proposed Public Offering of Common Stock

08 июн 2021 15:15:00 Источник Nasdaq GlobeNewswire

Aclaris Therapeutics Announces Positive Preliminary Topline Data from Phase 2a Trial of ATI-1777 for Moderate to Severe Atopic Dermatitis

08 июн 2021 06:00:00 Источник Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the Jefferies Virtual Healthcare Conference

17 май 2021 06:00:00 Источник Nasdaq GlobeNewswire

Aclaris Therapeutics Reports First Quarter 2021 Financial Results and Provides a Corporate Update

07 май 2021 06:00:01 Источник Nasdaq GlobeNewswire

Aclaris Therapeutics Completes Enrollment in its Phase 2a Clinical Trial of ATI-1777 for Moderate to Severe Atopic Dermatitis

15 мар 2021 06:00:01 Источник Nasdaq GlobeNewswire

Aclaris Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update

25 фев 2021 06:00:04 Источник Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in Upcoming Investor Conferences

22 фев 2021 06:00:00 Источник Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the 10th Annual SVB Leerink Global Healthcare Conference

10 фев 2021 06:00:00 Источник Nasdaq GlobeNewswire

Aclaris Announces Pricing of Public Offering of Common Stock

20 янв 2021 07:45:00 Источник Nasdaq GlobeNewswire

Aclaris Announces Proposed Public Offering of Common Stock

19 янв 2021 15:01:00 Источник Nasdaq GlobeNewswire

Aclaris Therapeutics Announces Positive Preliminary Topline Data from 12-Week Phase 2a Trial of Oral ATI-450 for Moderate to Severe Rheumatoid Arthritis

19 янв 2021 06:00:00 Источник Nasdaq GlobeNewswire